Orchestra BioMed (Nasdaq:OBIO) announced updated expectations for the timeline of its BACKBEAT cardiac pacing clinical trial.

Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...

Biventricular pacing is an excellent option for certain patients with advanced HF. Also known as “cardiac resynchronization therapy,” biventricular pacing has been shown to improve HF symptoms in a ...

The European Society of Cardiology (ESC) has released updated guidelines for cardiac pacing and cardiac resynchronization therapy (CRT), which emphasize patient-centered care and shared ...

When a heart patient with an implanted pacemakerundergoes electrocardiogram testing,the cardiologist must be able to detect thepresence and effects of the pacemaker (seesidebar, “When the heart’s ...

A leadless intracardiac transcatheter pacing system has been designed to avoid the need for a pacemaker pocket and transvenous lead. In a prospective multicenter study without controls, a ...

Personalized accelerated pacing at 75 bpm showed a reduction in adverse clinical events in HFpEF patients compared to standard 60 bpm pacing. The per-protocol analysis indicated significantly fewer ...

The use of pacemakers continues to grow as populations worldwide are living longer. It is estimated that around one million devices are implanted globally every year. Pacemakers are electrical devices ...

Reduced cardiac efficiency caused by suboptimal synchronization of the heart's normal contraction might contribute to the development of or exacerbate heart failure. Conceptually and in practice ...